Search

15 For '19: Key Clinical Data to Watch For Next Year

15 FOR '19: KEY CLINICAL DATA TO WATCH FOR NEXT YEAR

On Monday, Xconomy began our annual look ahead at clinical trials that could define biotech and have profound healthcare effects in...

15 For '19: Key Clinical Data To Watch For Next Year

15 FOR '19: KEY CLINICAL DATA TO WATCH FOR NEXT YEAR

It can take decades and billions of dollars to develop a drug, and its fate-and often that of its developer-rests in the outcome of...

 
 
 
Are You Washing Your Avocados? You Should Be

ARE YOU WASHING YOUR AVOCADOS? YOU SHOULD BE

A new report from the FDA shows that you should always be washing your avocados to prevent foodborne illness.

Johnson & Johnson Knew About Asbestos In Baby Powder, Didn't Report To FDA

JOHNSON & JOHNSON KNEW ABOUT ASBESTOS IN BABY POWDER, DIDN'T REPORT TO FDA

The earliest mentions of tainted J&J talc that Reuters found come from 1957 and 1958 reports by a consulting lab.

 
 
 
Bio Roundup: Eli Lilly Tries Tau, Generic Insulin, NASH Cash & More

BIO ROUNDUP: ELI LILLY TRIES TAU, GENERIC INSULIN, NASH CASH & MORE

Pharmaceutical industry critics lament the cost of rare disease drugs, but some of the steepest price hikes have come on widely used...

BULLETIN: FDA names California romaine farm as CDC reports additional E. coli patients

BULLETIN: FDA NAMES CALIFORNIA ROMAINE FARM AS CDC REPORTS ADDITIONAL E. COLI PATIENTS

They say the investigation is ongoing and more sources are possible, but as of this afternoon, the FDA is reporting traceback efforts...

 
 
 
Administration stops NIH scientists from obtaining fetal tissue, possibly threatening HIV research

ADMINISTRATION STOPS NIH SCIENTISTS FROM OBTAINING FETAL TISSUE, POSSIBLY THREATENING HIV RESEARCH

Science magazine reported that the move put the brakes on a preclinical HIV study and follows the cancellation of a contract between...

Black Diamond Emerges with $20M, Aiming for Cancer's Hidden Targets

BLACK DIAMOND EMERGES WITH $20M, AIMING FOR CANCER'S HIDDEN TARGETS

Nearly two years ago, Versant Ventures used some of its new $400 million fund to set up a drug discovery unit in Europe. The goal was...

 
 
 
 
 
 
More romaine victims reported - FDA says look to industry for change; industry says additional study needed

MORE ROMAINE VICTIMS REPORTED - FDA SAYS LOOK TO INDUSTRY FOR CHANGE; INDUSTRY SAYS ADDITIONAL STUDY NEEDED

The FDA says shipping records show at least 10 distributors, 11 farms and 12 growers in the romaine lettuce supply chain are implicated...

OncoMed's Saga Ends in Reverse Merger with UK-Based Mereo BioPharma

ONCOMED'S SAGA ENDS IN REVERSE MERGER WITH UK-BASED MEREO BIOPHARMA

OncoMed Pharmaceuticals attracted hundreds of millions of dollars from investors and pharmaceutical partners with compounds it developed...

 
 
 
Adherium Aims to Improve Asthma Patient Outcomes with Smart Inhalers

ADHERIUM AIMS TO IMPROVE ASTHMA PATIENT OUTCOMES WITH SMART INHALERS

Asthma is the third-ranking cause of hospitalization for children under 15 years of age in the U.S., and it's the leading cause of...

Too Much Vitamin D In Dog Food May Have Poisoned Pets, Spurring Recalls And FDA Alert

TOO MUCH VITAMIN D IN DOG FOOD MAY HAVE POISONED PETS, SPURRING RECALLS AND FDA ALERT

The FDA says pet owners should watch out for vitamin D toxicity. Recalled brands include Abound, Nutrisca and Natural Life. (Image...

 
 
 
Take this FDA-approved diabetes drug, and you might have to amputate your leg, warns the FDA

TAKE THIS FDA-APPROVED DIABETES DRUG, AND YOU MIGHT HAVE TO AMPUTATE YOUR LEG, WARNS THE FDA

The U.S. Food and Drug Administration has recently issued a black box warning against Johnson & Johnson's Type 2 diabetes drug Invokana...

FDA approval puts Loxo, Bayer's Vitrakvi on the rails to value-based care

FDA APPROVAL PUTS LOXO, BAYER'S VITRAKVI ON THE RAILS TO VALUE-BASED CARE

That the drug will only be given to patients shown through testing to harbor a genetic anomaly that increases the odds of a response...

 
 
 
Alkermes Schizophrenia Drug Heads To FDA, But Questions Linger

ALKERMES SCHIZOPHRENIA DRUG HEADS TO FDA, BUT QUESTIONS LINGER

Alkermes got some much-needed good news on Thursday, announcing that an experimental schizophrenia drug fared better than a staple...

FDA Announces First Steps in Medical Device Approval Overhaul

FDA ANNOUNCES FIRST STEPS IN MEDICAL DEVICE APPROVAL OVERHAUL

On November 20, 2018, the U.S. Food and Drug Administration released a statement outlining the steps it is taking to overhaul its existing...

 
 
 
FDA approves Celltrion, Teva's Rituxan biosimilar, but with a narrow label

FDA APPROVES CELLTRION, TEVA'S RITUXAN BIOSIMILAR, BUT WITH A NARROW LABEL

The agency approved Truxima for three lymphoma indications, whereas European regulators approved it last year for all the same indications...

FDA finds heavy metals in kratom products; says no benefits in the supplement

FDA FINDS HEAVY METALS IN KRATOM PRODUCTS; SAYS NO BENEFITS IN THE SUPPLEMENT

A new warning from the FDA reports multiple tests have found heavy metals in multiple kratom products. The alert comes after warnings...